CureVac Withdraws Covid Vaccine Application in Europe

The German company will also terminate an advance purchase agreement with the European Commission for 405 million doses of the vaccine.

Source: NYT Health - October 12, 2021 Category: Consumer Health News Authors: Carl Zimmer Tags: Coronavirus (2019-nCoV) Clinical Trials Vaccination and Immunization RNA (Ribonucleic Acid) Regulation and Deregulation of Industry CureVac GmbH European Commission Source Type: news